Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2634)
All Articles published online
|
Oct 14, 2008 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Azim J, McCurdy H, Moseley RH. Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C. World J Gastroenterol 2008; 14(38): 5913-5915 [PMID: 18855993 DOI: 10.3748/wjg.14.5913] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i38/5913.htm |
| Number | Citing Articles |
| 1 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. MacSween's Pathology of the Liver. 2024; : 122 doi: 10.1016/B978-0-7020-8228-3.00003-X
|
| 2 |
María Teresa Bordel-Gómez. Porfiria cutánea tarda esporádica por interferón-β1a en un paciente con esclerosis múltiple. Piel 2021; 36(7): 498 doi: 10.1016/j.piel.2020.10.015
|
| 3 |
Simone Garcovich, Matteo Garcovich, Rodolfo Capizzi, Antonio Gasbarrini, Maria Assunta Zocco. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World Journal of Hepatology 2015; 7(27): 2740-2748 doi: 10.4254/wjh.v7.i27.2740
|
| 4 |
Lucio J. García-Fraile, Luisa García-Buey, Concepción Alonso Cerezo, Jesús Sanz Sanz, Ignacio de los Santos Gil. Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals. Gastroenterología y Hepatología 2022; 45(4): 249 doi: 10.1016/j.gastrohep.2021.09.001
|
| 5 |
F. Ryan Caballes, Hossein Sendi, Herbert L. Bonkovsky. Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver International 2012; 32(6): 880 doi: 10.1111/j.1478-3231.2012.02794.x
|
| 6 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
|
| 7 |
|
| 8 |
E. Delaporte, S. Buche, F. Piette. Manifestaciones cutaneomucosas de las enfermedades hepatobiliares y pancreáticas. EMC - Dermatología 2012; 46(1): 1 doi: 10.1016/S1761-2896(12)60832-2
|
| 9 |
Alberto Quaglia, Eve A. Roberts, Michael Torbenson. Macsween's Pathology of the Liver. 2018; : 111 doi: 10.1016/B978-0-7020-6697-9.00003-0
|
| 10 |
Ashwani K. Singal, Krishna V.R. Venkata, Sarat Jampana, Fakhar-Ul Islam, Karl E. Anderson. Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda. The American Journal of the Medical Sciences 2017; 353(6): 523 doi: 10.1016/j.amjms.2017.03.007
|
| 11 |
Taoufik Amezyane, Ali Abouzahir, Jamal Fatihi, Youssef Sekkach, Fatima Mahassin, Omar Sedrati, Driss Ghafir, Victor Ohayon. A Sclerodermiform Porphyria Cutanea Tarda. Internal Medicine 2010; 49(2): 205 doi: 10.2169/internalmedicine.49.2888
|
| 12 |
L.E. Wiznia, M.E. Laird, A.G. Franks. Hepatitis C virus and its cutaneous manifestations: treatment in the direct‐acting antiviral era. Journal of the European Academy of Dermatology and Venereology 2017; 31(8): 1260 doi: 10.1111/jdv.14186
|
| 13 |
Suzanne Tintle, Ali Alikhan, Mary E. Horner, Jennifer L. Hand, Dawn Marie R. Davis. Cutaneous porphyrias part II: treatment strategies. International Journal of Dermatology 2014; 53(1): 3 doi: 10.1111/ijd.12016
|
| 14 |
M.M. Hatch, Z. Nawas, R. Kollipara, S.K. Tyring. Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?. Journal of the European Academy of Dermatology and Venereology 2017; 31(4) doi: 10.1111/jdv.13936
|
| 15 |
Uyen Ngoc Mui, Christopher T. Haley, Ramya Vangipuram, Stephen K. Tyring. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention. Journal of the American Academy of Dermatology 2019; 81(1): 23 doi: 10.1016/j.jaad.2018.10.072
|
| 16 |
U. Floristán, R. Feltes, P. Ramírez-Marín, P. Herranz-Pinto. Interferón alfa y virus hepatitis C: la piel importa. Revista Clínica Española 2011; 211(2): 92 doi: 10.1016/j.rce.2010.05.026
|
| 17 |
Richard J. Thompson, Bernard C. Portmann, Eve A. Roberts. MacSween's Pathology of the Liver. 2012; : 157 doi: 10.1016/B978-0-7020-3398-8.00004-0
|
| 18 |
E. Delaporte, S. Buche, F. Piette. Manifestations cutanéomuqueuses des affections hépatobiliaires et pancréatiques. EMC - Dermatologie 2011; 6(4): 1 doi: 10.1016/S0246-0319(11)57958-0
|
| 19 |
Andrew Aronsohn, Donald Jensen. HCV Eradication: Implications for Disease Resolution. Current Hepatitis Reports 2011; 10(1): 27 doi: 10.1007/s11901-010-0076-9
|
| 20 |
Michael W. Fried, Jama M. Darling, Stanley M. Lemon. Schiff's Diseases of the Liver. 2017; : 628 doi: 10.1002/9781119251316.ch25
|
| 21 |
Nancy S. Handler, Marc Z. Handler, Matthew P. Stephany, Glenn A. Handler, Robert A. Schwartz. Porphyria cutanea tarda: an intriguing genetic disease and marker. International Journal of Dermatology 2017; 56(6) doi: 10.1111/ijd.13580
|
| 22 |
|
| 23 |
Jama M. Darling, Stanley M. Lemon, Michael W. Fried. Schiff's Diseases of the Liver. 2011; : 582 doi: 10.1002/9781119950509.ch25
|
| 24 |
Lucio J. García-Fraile, Luisa García-Buey, Concepción Alonso Cerezo, Jesús Sanz Sanz, Ignacio de los Santos Gil. Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals. Gastroenterología y Hepatología (English Edition) 2022; 45(4): 249 doi: 10.1016/j.gastre.2021.09.007
|
| 25 |
Adriano M. Pellicelli, Aldo Morrone, Luca Barbieri, Arnaldo Andreoli. Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report. Annals of Hepatology 2012; 11(6): 951 doi: 10.1016/S1665-2681(19)31424-3
|